Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:337-341
Published online before print December 18, 2003, doi: 10.1161/01.ATV.0000113292.00300.55
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/2/337    most recent
01.ATV.0000113292.00300.55v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engström, G.
Right arrow Articles by Lindgärde, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engström, G.
Right arrow Articles by Lindgärde, F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Aortic Aneurysm
Related Collections
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:337.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Incidence of Fatal or Repaired Abdominal Aortic Aneurysm in Relation to Inflammation-Sensitive Plasma Proteins

Gunnar Engström; Gabriel Börner; Bengt Lindblad; Lars Janzon; Folke Lindgärde

From the Departments of Community Medicine (G.E., L.J.), Vascular Surgery (G.B., B.L.), and Vascular Diseases (F.L.), Lund University, Malmö University Hospital, Sweden.

Correspondence to Gunnar Engström, MD, PhD, Department of Community Medicine, Malmö University Hospital, S-20502 Malmö, Sweden. E-mail Gunnar.Engstrom{at}smi.mas.lu.se

Background— Inflammation is an important pathophysiological feature of abdominal aortic aneurysms (AAA). Whether elevated levels of inflammation-sensitive plasma proteins (ISPs) predict the long-term risk of fatal or repaired AAA is largely unknown.

Methods and Results— Five ISPs (fibrinogen, orosomucoid, {alpha}1-antitrypsin, haptoglobin, and ceruloplasmin) were measured in 6075 healthy men, mean age 46.8±3.7 years. After a mean time of 19 years, 63 men had a fatal or surgically/endovascularly repaired AAA. Risk of treatment or death from future AAA was studied in relation to the ISPs. The risk of future AAA increased significantly with the number of elevated ISPs (ie, in the top quartile). The proportions with future AAA were 0.4%, 1.0%, 1.3%, and 2.3% for men with none, one, two, and >=3 ISPs, respectively, in the top quartile (trend: P<0.0001). The corresponding odds ratios were 1.00 (reference), 1.9 (95% CI: 0.8 to 4.5), 2.2 (0.9 to 5.5), and 3.2 (1.4 to 7.2), respectively, adjusted for age, screening year, smoking, cholesterol, triglycerides, systolic blood pressure and physical inactivity (trend: P=0.004).

Conclusion— The incidence of fatal or repaired AAA is associated with the ISP levels. In this population-based study, elevated ISPs could be observed many years before the clinical manifestation of disease.


Key Words: aneurysm • inflammation • epidemiology




This article has been cited by other articles:


Home page
CirculationHome page
J. Golledge, P. S. Tsao, R. L. Dalman, and P. E. Norman
Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression
Circulation, December 2, 2008; 118(23): 2382 - 2392.
[Full Text] [PDF]